1. Proposal to Consider Chemical/Physical Microenvironment as a New Therapeutic Off-Target Approach
   Alessandro Giuliani et al, 2022, Pharmaceutics CrossRef
2. Ruthenium(ii) p-cymene complexes of a benzimidazole-based ligand capable of VEGFR2 inhibition: hydrolysis, reactivity and cytotoxicity studies
   Sudipta Bhattacharyya et al, 2017, Dalton Transactions CrossRef
3. LASS2 overexpression enhances early apoptosis of lung cancer cells through the caspase‑dependent pathway
   Yamei Wang et al, 2022, Oncology Reports CrossRef
4. Targeting acidity in cancer and diabetes
   Robert J. Gillies et al, 2019, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
5. 2-(1H-Benzimidazol-2-yl)-4,5,6,7-tetrahydro-2H-indazol-3-ol, a Benzimidazole Derivative, Inhibits T Cell Proliferation Involving H+/K+-ATPase Inhibition
   Jin Liu et al, 2014, Molecules CrossRef
6. Mitochondria: Participation to infertility as source of energy and cause of senescence
   Moncef Benkhalifa et al, 2014, The International Journal of Biochemistry & Cell Biology CrossRef
7. ROS-Dependent Antiproliferative Effect of Brassinin Derivative Homobrassinin in Human Colorectal Cancer Caco2 Cells
   Martin Kello et al, 2014, Molecules CrossRef
8. Lactic Acidosis in Patients with Solid Cancer
   Petr Heneberg, 2022, Antioxidants & Redox Signaling CrossRef
9. Pepsin enhances glycolysis to promote malignant transformation of vocal fold leukoplakia epithelial cells with dysplasia
   Haitong Li et al, 2023, European Archives of Oto-Rhino-Laryngology CrossRef